Patient Characteristics According to Status of Leukemia at Transplantation
Status of Disease . | No. of Patients (N = 60) . | Median Age (range) yr . | Median Time Since Diagnosis (range) mo . |
---|---|---|---|
ALL | 22 | 16 (4-27) | 17 (4-66) |
First complete remission | 4* | ||
Second or third complete remission | 10 | ||
Advanced relapse | 8 | ||
AML | 25 | 33 (7-53) | 10 (4-55) |
First complete remission | 4† | ||
Second or third complete remission | 14 | ||
Advanced relapse | 7 | ||
CML | 13 | 28 (18-45) | 31 (12-177) |
Accelerated phase | 8 | ||
Blastic crisis | 5 |
Status of Disease . | No. of Patients (N = 60) . | Median Age (range) yr . | Median Time Since Diagnosis (range) mo . |
---|---|---|---|
ALL | 22 | 16 (4-27) | 17 (4-66) |
First complete remission | 4* | ||
Second or third complete remission | 10 | ||
Advanced relapse | 8 | ||
AML | 25 | 33 (7-53) | 10 (4-55) |
First complete remission | 4† | ||
Second or third complete remission | 14 | ||
Advanced relapse | 7 | ||
CML | 13 | 28 (18-45) | 31 (12-177) |
Accelerated phase | 8 | ||
Blastic crisis | 5 |
For patients with ALL in first remission the prognosis was poor; in 1 first-line induction therapy had failed, 2 had the t(9;22) translocation, and 1 had the T phenotype with bulky disease.
For 3 patients with AML in first remission, the prognosis was poor; 2 had myelodysplasia and in 1 first-line induction therapy had failed.